Navigation Links
"Tomorrow's Health" TV Series Showing the Life Science Industry's Quest to Save and Improve Lives, to Air on Select NBC Stations
Date:11/7/2011

SAN DIEGO, Nov. 7, 2011 /PRNewswire/ -- BIOCOM, the trade group representing Southern California's life science industry, and award-winning Phase 3 Digital have partnered to tell the biotechnology story from discovery through development. Consumers across the U.S. will soon get a glimpse into the exciting and innovative world of medical discovery that brings life-saving therapies, medical devices and diagnostics to patients around the globe. "Tomorrow's Health," a new television series created in partnership with the life sciences industry, explores some of the most exciting and promising new treatments under development.

"Tomorrow's Health" introduces viewers to patients, their doctors, and their struggle to achieve healthier lives. The program reveals the surprising truth about the challenges and obstacles biomedical researchers face in the development of cures and bringing new medicines, medical devices and diagnostics to market.

Created and produced by Phase 3 Digital, in partnership with BIOCOM, "Tomorrow's Health" will run on select NBC stations and other major network and cable channels in top media markets around the U.S. The program will feature a website and social media portals, where consumers can view episodes on demand and gain more information on companies and the featured experts.

For more information on how to be considered as a featured company, sponsorship opportunities, or other information contact Ed Personius at Phase 3 Digital, at (714) 748-0600.


'/>"/>
SOURCE BIOCOM
Copyright©2010 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. Karyopharm Therapeutics Closes $10 Million Series A2 Financing to Expand Planned Phase 1 Program of Oral Selective Inhibitors of Nuclear Export (SINE) for Cancer
2. Life Technologies Launches 3500 Dx Series Genetic Analyzers for In Vitro Diagnostic Use in China
3. Pfizer, Sanofi and Genentech Feature Prominently in the Oncology Edition of PharmaDeals New Publication Series; Essential Deal Trends
4. Cleave Biosciences Raises $42 Million in Series A Financing for Novel Cancer Therapies
5. Creabilis Raises €15M ($20M) in Series B Fundraising Round
6. Spinifex Closes AU$18.25M(~US$19M) Expanded Series B Round
7. SironRX Therapeutics Raises $3.4 Million Series A
8. Peloton Therapeutics Completes $18 Million Series A Financing
9. Health Diagnostic Laboratory Inc. Sponsors Lecture Series in West Palm Beach, Florida
10. Northwest Biotherapeutics Announces Series of Financing Arrangements
11. Naurex Completes $18 Million Series A Financing
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/12/2017)... ... October 12, 2017 , ... ... multicenter, prospective clinical study that demonstrates the accuracy of the FebriDx® test, ... clinically significant acute bacterial and viral respiratory tract infections by testing the ...
(Date:10/12/2017)... ... ... AMRI, a global contract research, development and manufacturing organization ... quality of life, will now be offering its impurity solutions as a stand-alone ... for all new drug products, including the finalization of ICH M7 earlier this ...
(Date:10/11/2017)... , ... October 11, 2017 , ... ... President Andi Purple announced Dr. Suneel I. Sheikh, the co-founder, CEO and ... Labs ), Inc. has been selected for membership in ARCS Alumni Hall ...
(Date:10/11/2017)... ... ... eye wash is a basic first aid supply for any work environment, but most personal ... rinse first if a dangerous substance enters both eyes? It’s one less decision, and likely ... dual eye piece. , “Whether its dirt and debris, or an acid or alkali, getting ...
Breaking Biology Technology:
(Date:4/6/2017)... -- Forecasts by Product Type (EAC), Biometrics, ... (Transportation & Logistics, Government & Public Sector, Utilities / ... Facility, Nuclear Power), Industrial, Retail, Business Organisation (BFSI), Hospitality ... looking for a definitive report on the $27.9bn Access ... ...
(Date:4/4/2017)... YORK , April 4, 2017   EyeLock ... today announced that the United States Patent and Trademark ... patent broadly covers the linking of an iris image ... same transaction) and represents the company,s 45 th ... latest patent is very timely given the multi-modal biometric ...
(Date:3/30/2017)... 30, 2017 Trends, opportunities and forecast in ... by technology (fingerprint, AFIS, iris recognition, facial recognition, hand ... by end use industry (government and law enforcement, commercial ... banking, and others), and by region ( North ... Asia Pacific , and the Rest of ...
Breaking Biology News(10 mins):